178 related articles for article (PubMed ID: 8571479)
1. [Changes in the picture of chronic diseases on long-term hemodialysis treatment].
von Appen K; Ivanovich P; Klinkmann H; Stetsiuk E
Urol Nefrol (Mosk); 1995; (5):25-7. PubMed ID: 8571479
[TBL] [Abstract][Full Text] [Related]
2. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
Czyz W; Szepietowski T
Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
[TBL] [Abstract][Full Text] [Related]
3. [Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis].
Ritz E; Bommer J; Zeier M
Dtsch Med Wochenschr; 1988 Feb; 113(5):190-6. PubMed ID: 3276494
[No Abstract] [Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Amyloidosis in patients with end-stage renal failure: uraemia associated or dialysis related?
Davison AM
Contrib Nephrol; 1995; 113():92-100. PubMed ID: 7712726
[No Abstract] [Full Text] [Related]
6. Are biocompatible membranes superior for hemodialysis therapy?
van Ypersele de Strihou C
Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
[No Abstract] [Full Text] [Related]
7. beta 2-microglobulin and amyloidosis: who is at risk?
Davison AM
Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
[No Abstract] [Full Text] [Related]
8. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
[TBL] [Abstract][Full Text] [Related]
9. Concentration of plasma middle molecular weight substances and clinical condition of patients undergoing short-time regular dialysis treatment.
Válek A; Dzúrik R; Spustová V; Válková D
Artif Organs; 1981; 4 Suppl():173-6. PubMed ID: 7295088
[TBL] [Abstract][Full Text] [Related]
10. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
[TBL] [Abstract][Full Text] [Related]
11. The hemodialysis membranes: a historical perspective, current state and future prospect.
Cheung AK; Leypoldt JK
Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
[TBL] [Abstract][Full Text] [Related]
12. Malignant neoplasms in long-term hemodialysis patients.
Olusegun Fayemi A; Ali M
J Med Soc N J; 1979 Jul; 76(7):497-500. PubMed ID: 289847
[No Abstract] [Full Text] [Related]
13. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW
Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821
[No Abstract] [Full Text] [Related]
14. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
[TBL] [Abstract][Full Text] [Related]
15. [The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by hemodialysis].
Król Z; Morawska Z
Pediatr Pol; 1996 Feb; 71(2):121-5. PubMed ID: 8966077
[TBL] [Abstract][Full Text] [Related]
16. The effect of high-flux hemodialysis on dialysis-associated amyloidosis.
Ayli M; Ayli D; Azak A; Yüksel C; Atilgan G; Dede F; Akalin T; Abayli E; Camlibel M
Ren Fail; 2005; 27(1):31-4. PubMed ID: 15717632
[TBL] [Abstract][Full Text] [Related]
17. [Renal replacement therapy by hemodialysis: an overview].
Jacobs C
Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
[TBL] [Abstract][Full Text] [Related]
18. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
Rinaudo JB; Gallice P; Crevat A; Saingra S; Murisasco A
Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
[TBL] [Abstract][Full Text] [Related]
19. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
[TBL] [Abstract][Full Text] [Related]
20. Dialysis-related amyloidosis: late finding or hidden epidemic?
Dember LM; Jaber BL
Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
